Trial Profile
Racial Differences in Vagal Control of Glucose Homeostasis, Chronic Study
Status:
Withdrawn prior to enrolment
Phase of Trial:
Phase I
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Galantamine (Primary)
- Indications Alzheimer's disease; Down syndrome
- Focus Therapeutic Use
- Acronyms RDVCGH
- 09 Aug 2018 Status changed from recruiting to withdrawn prior to enrolment as no fundings available
- 23 Jan 2018 Status changed to recruiting.
- 12 Jan 2017 New trial record